• Magnetic Stimulation Targets GABRE in Schizophrenia Mice

  2026-09-08

  A Molecular Psychiatry study identifies the GABAA receptor ε subunit, encoded by Gabre, in the left prelimbic cortex as a responsive molecular target of selective magnetic stimulation. Using pharmacological, genetic, behavioral, and synaptic approaches, the authors connect GABRE regulation with the reversal of schizophrenia-like phenotypes and implicate p62/SQSTM1–GABARAP trafficking in the response.

• Sphingosine-1-phosphate: From Ligand to Translation

  2026-09-08

  Sphingosine-1-phosphate is a context-dependent signaling tool whose effects range from vascular maturation and survival signaling to receptor-specific neuronal apoptosis. This thought-leadership article connects S1P biology with experimental design, translational positioning, and reproducible workflow strategy.

• Demethyleneberberine in Huntington’s Disease Research

  2026-09-07

  The reference paper proposes Demethyleneberberine (DMB) as a hypothesis-generating, multi-pathway candidate for Huntington’s disease by connecting oxidative stress, mitochondrial dysfunction, neuroinflammation, and neuronal apoptosis. Its main value is mechanistic integration rather than direct therapeutic validation, providing a framework for designing focused preclinical studies.

• Indazole/Indole Glucagon Receptor Antagonists

  2026-09-07

  This 2015 study introduced indazole- and indole-based glucagon receptor antagonists derived from the MK-0893 framework and used focused SAR to optimize key scaffold positions. Several compounds combined strong in vitro activity with favorable rat pharmacokinetics, while GRA 16d produced oral glucose-lowering effects in humanized glucagon receptor mouse models.

• Aminopeptidase Selectivity and ACE Inhibitor Action

  2026-09-05

  The reference study re-evaluated how bestatin and related metallopeptidase inhibitors act across aminopeptidases A, N, and W, revealing that bestatin is relatively selective for AP-W rather than AP-N or AP-A. Its direct comparison of inhibitor classes provides an important caution for interpreting ACE inhibitor experiments: inhibition of angiotensin converting enzyme does not automatically predict inhibition of related cell-surface aminopeptidases.

• Bestatin Hydrochloride: From Enzymes to Translation

  2026-09-04

  Bestatin hydrochloride, also known as Ubenimex, offers translational researchers a mechanistic way to connect aminopeptidase activity with peptide signaling, angiogenesis inhibition, tumor growth and invasion research, and experimental cancer biology. This article examines the evidence, workflow design, limitations, and strategic opportunities surrounding the compound.

• Fumagillin and Azumiobodo hoyamushi: Study Insights

  2026-09-04

  The reference study established a comparative framework for testing 20 compounds against Azumiobodo hoyamushi, the protozoan associated with soft tunic syndrome in cultured ascidians. Fumagillin showed moderate in vitro antiparasitic activity, whereas formalin and chlorine dioxide produced the clearest reduction of parasite burden in experimentally infected Halocynthia roretzi.

• Ceapin-A7 for ATF6α ER Stress Studies

  2026-09-03

  Ceapin-A7 enables branch-resolved analysis of the unfolded protein response by selectively perturbing ATF6α rather than suppressing all endoplasmic reticulum stress. This makes it a practical complement to PERK-focused nucleus pulposus cell assays investigating pyroptosis, inflammation, and JAK1–STAT3 signaling.

• Fumagillin: From MetAP-2 Mechanism to Assay Design

  2026-09-03

  Fumagillin is a methionine aminopeptidase-2 inhibitor with established value in angiogenesis and tumor-growth research. This guide interprets its cross-domain evidence and converts it into practical decisions for concentration-response, host-compatibility, and endpoint design.

• Fumagillin: From MetAP-2 Biology to Translation

  2026-09-02

  Fumagillin is more than an antiangiogenic research reagent: it is a mechanistically defined methionine aminopeptidase-2 inhibitor that can connect endothelial biology, tumor-induced angiogenesis inhibition, and exploratory antiparasitic research. The strongest translational lesson is not simply whether the compound works, but how target biology, formulation, exposure, and host context determine whether in vitro activity becomes a useful model or a viable intervention.

• Losartan Workflows for Hypertension Research

  2026-09-02

  Build more informative hypertension and vascular assays with Losartan, a selective angiotensin II receptor antagonist that enables receptor-level interrogation of AT1 signaling. This guide connects vascular smooth muscle experiments with emerging podocyte-protection research while emphasizing practical dosing, controls, and troubleshooting.

• Okadaic acid: PP1/PP2A Inhibition Guide

  2026-09-01

  Okadaic acid (A4540) provides nanomolar inhibition of PP2A and PP1 for testing phosphorylation-dependent signaling and apoptosis-related endpoints. It is suited to controlled biochemical and cell-based experiments, but not to broad phosphatase inhibition, therapeutic use, or mechanistic conclusions based on apoptosis alone.

• Dexamethasone (DHAP): Time-Resolved Assay Design

  2026-09-01

  Dexamethasone is a glucocorticoid anti-inflammatory reagent whose biological effects depend strongly on exposure timing, cell state, and endpoint selection. This guide presents a time-resolved framework for studying NF-κB regulation, neuroinflammation, stem cell differentiation, autophagy, and RhoB biology with clearer causal interpretation.

• Angiotensin (1-7): Mechanism and Research Use

  2026-08-31

  Angiotensin (1-7), also known as Asp-Arg-Val-Tyr-Ile-His-Pro, is an endogenous heptapeptide that signals mainly through Mas and counter-regulates selected angiotensin II responses. The A1041 research reagent combines a defined peptide sequence with reported purity above 99.7%, water and DMSO solubility specifications, and preclinical model benchmarks.

• Periodontopathogens Redirect Angiotensin I to Ang-(1-7)

  2026-08-31

  The reference study shows that Porphyromonas gingivalis and Tannerella forsythia can reshape local renin–angiotensin system chemistry through surface-associated PepO metalloproteases that hydrolyze angiotensin I toward Angiotensin (1-7). Structural, biochemical, cellular, and infection-model data connect bacterial protease specificity with a potentially important mechanism linking periodontitis to host peptide signaling.

7739 records 1/516 page Next 12345 下5页 Last page